Export this Abstract | Print this Abstract | Add to my preferred Abstracts list | My preferred Abstracts list (9) | Back to Search
Investigation of polycaprolactone matrices containing doxycycline and metronidazole for the treatment of pelvic inflammatory disease
- In: SUBMITTED ORALS on Tuesday, 15 April 2014, 16:00-17:30
- At: PSWC, Melbourne (Australia) (2014)
- Type: Presentation
- By: PATHAK, Meenakshi (University of Queensland, School of pharmacy, Brisbane, Australia)
- Co-author(s): Coombes, Allan (The International Medical University, Kuala lumpur, Malaysia)
Turner, Mark (School of Agriculture and Food Sciences, The University of Queensland, Brisbane, Australia)
Palmer, Cheryn (Princess Alexandra Hospital, Dept. of Sexual health, Brisbane, Australia)
Steadman, Kathryn (School of Pharmacy, The University of Queensland, Brisbane, Australia) - Abstract:
Pelvic inflammatory disease (PID) is a problem among women of reproductive age and is most commonly caused by gonorrhoea and chlamydia infections. Therapy is usually doxycycline 100 mg twice per day for 2-4 weeks combined with metronidazole 400 mg three times per day for 2-4 weeks; however patient compliance is poor due to adverse effects and long ..
The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress.
Please login
Last update 28 September 2023